Is Motixafortide legal in the US?
Yes, FDA approved for collecting stem cells in people with multiple myeloma.
AStrong human evidenceFDA approvedas of 2026-10-26
Approved. Motixafortide (Aphexda) was approved in September 2023 for use with filgrastim to mobilize hematopoietic stem cells for collection and autologous transplantation in patients with multiple myeloma. It has no other approved indication as of the 2026 label revision. 2
Read the full Motixafortide page
More on Motixafortide
Citations
- Crees 2023, Nature Medicine: Motixafortide and G-CSF for stem cell mobilization in multiple myeloma (GENESIS) doi.org
- FDA 2026: Aphexda (motixafortide) prescribing information accessdata.fda.gov
Reference information only, not medical advice. Drawn from the Motixafortide article, fact-checked against the cited sources. No dosing anywhere on this site.